These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

655 related articles for article (PubMed ID: 33236823)

  • 41. Oral mucosal lesions associated with the wearing of removable dentures.
    Budtz-Jørgensen E
    J Oral Pathol; 1981 Apr; 10(2):65-80. PubMed ID: 6792333
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Periodontal disease and COVID-19: Prognosis and potential pathways of association in their pathogenesis.
    Carmona Loayza DA; Lafebre MF
    Can J Dent Hyg; 2023 Feb; 57(1):44-51. PubMed ID: 36968799
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Oral Manifestations in Pediatric Patients with Coeliac Disease - A Review Article.
    Macho VMP; Coelho AS; Veloso E Silva DM; de Andrade DJC
    Open Dent J; 2017; 11():539-545. PubMed ID: 29238414
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparative study: Oral mucosal lesions, signs and symptoms in diabetes mellitus patients with end stage renal disease with analogous findings in diabetes mellitus patients with non-end stage renal disease.
    Senthil B; Shanmugam S; Elangovan S; Elumalai Chandramouli PG; Bhaskaran S; Ramesh C
    Indian J Dent Res; 2017; 28(4):406-412. PubMed ID: 28836532
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Publishing in pandemic times: A bibliometric analysis of early medical publications on Kawasaki-like disease (MIS-C, PIMS-TS) related to SARS-CoV-2.
    Morand A; Urbina D; Giovannini-Chami L; Fabre A
    Arch Pediatr; 2021 Aug; 28(6):464-469. PubMed ID: 34140220
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Are oral manifestations related to SARS-CoV-2 mediated hemolysis and anemia?
    Sarode GS; Sarode SC; Gadbail AR; Gondivkar S; Sharma NK; Patil S
    Med Hypotheses; 2021 Jan; 146():110413. PubMed ID: 33261916
    [No Abstract]   [Full Text] [Related]  

  • 47. COVID-19 manifestation in the oral cavity - a narrative literature review.
    Kusiak A; Cichońska D; Tubaja M; Skorek A; Jereczek-Fossa BA; Corrao G; Marvaso G; Alterio D
    Acta Otorhinolaryngol Ital; 2021 Oct; 41(5):395-400. PubMed ID: 34734574
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Oral manifestations of COVID-19 patients: An online survey of the Egyptian population.
    El Kady DM; Gomaa EA; Abdella WS; Ashraf Hussien R; Abd ElAziz RH; Khater AGA
    Clin Exp Dent Res; 2021 Oct; 7(5):852-860. PubMed ID: 33931952
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Oral mucosal lesions in a COVID-19 patient: New signs or secondary manifestations?
    Amorim Dos Santos J; Normando AGC; Carvalho da Silva RL; De Paula RM; Cembranel AC; Santos-Silva AR; Guerra ENS
    Int J Infect Dis; 2020 Aug; 97():326-328. PubMed ID: 32526392
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Photobiomodulation (PBMT) and antimicrobial photodynamic therapy (aPDT) in oral manifestations of patients infected by Sars-CoV-2: systematic review and meta-analysis.
    Pacheco JA; Molena KF; Martins CROG; Corona SAM; Borsatto MC
    Bull Natl Res Cent; 2022; 46(1):140. PubMed ID: 35601476
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dermatological Manifestations in Pediatric Inflammatory Bowel Disease.
    Diaconescu S; Strat S; Balan GG; Anton C; Stefanescu G; Ioniuc I; Stanescu AMA
    Medicina (Kaunas); 2020 Aug; 56(9):. PubMed ID: 32842528
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Oral manifestations of HIV infection: a Panamerican perspective.
    Gillespie GM; Mariño R
    J Oral Pathol Med; 1993 Jan; 22(1):2-7. PubMed ID: 7678293
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Oral signs and symptoms in 160 Greek HIV-infected patients.
    Laskaris G; Hadjivassiliou M; Stratigos J
    J Oral Pathol Med; 1992 Mar; 21(3):120-3. PubMed ID: 1316436
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Oral manifestations among COVID-19: An observational study of 713 patients.
    Subramaniam T; Nikalje MR; Jadhav S
    Dent Res J (Isfahan); 2021; 18():67. PubMed ID: 34584645
    [TBL] [Abstract][Full Text] [Related]  

  • 55. New Approach to Addison Disease: Oral Manifestations Due to Endocrine Dysfunction and Comorbidity Burden.
    Bugălă NM; Carsote M; Stoica LE; Albulescu DM; Ţuculină MJ; Preda SA; Boicea AR; Alexandru DO
    Diagnostics (Basel); 2022 Aug; 12(9):. PubMed ID: 36140482
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Oral pathology in inflammatory bowel disease.
    Muhvić-Urek M; Tomac-Stojmenović M; Mijandrušić-Sinčić B
    World J Gastroenterol; 2016 Jul; 22(25):5655-67. PubMed ID: 27433081
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Increased odds ratio for COVID-19 in patients with recurrent aphthous stomatitis.
    Katz J; Yue S
    J Oral Pathol Med; 2021 Jan; 50(1):114-117. PubMed ID: 33064856
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Could the oral cavity be a target organ in SARS-CoV-2 infection?
    Kumar S
    Evid Based Dent; 2021 Jan; 22(2):78-79. PubMed ID: 34172916
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Oral mucosal lesions in older people: relation to salivary secretion, systemic diseases and medications.
    Lynge Pedersen AM; Nauntofte B; Smidt D; Torpet LA
    Oral Dis; 2015 Sep; 21(6):721-9. PubMed ID: 25754744
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Oral mucosal lesions in patients with COVID-19: a systematic review.
    Bhujel N; Zaheer K; Singh RP
    Br J Oral Maxillofac Surg; 2021 Nov; 59(9):1024-1030. PubMed ID: 34563354
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.